DHL

2-AMINO-ETHANETHIOL

Created:1999-11-22
Last modified:  2024-09-27

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count11
Chiral Atom Count0
Bond Count10
Aromatic Bond Count0
2D diagram of DHL

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

Name2-AMINO-ETHANETHIOL
Synonyms2,3-DESHYDROLANTHIONINE
Systematic Name (OpenEye OEToolkits)2-aminoethanethiol
FormulaC2 H7 N S
Molecular Weight77.149
TypeL-PEPTIDE LINKING

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs10.04SCCN
SMILESCACTVS3.341NCCS
SMILESOpenEye OEToolkits1.5.0C(CS)N
Canonical SMILESCACTVS3.341 NCCS
Canonical SMILESOpenEye OEToolkits1.5.0 C(CS)N
InChIInChI1.03 InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2
InChIKeyInChI1.03 UFULAYFCSOUIOV-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00847 
NameCysteamine
Groups
  • approved
  • investigational
DescriptionCystinosis is a rare disease caused by mutations in the CTNS gene that encodes for cystinosin, a protein responsible for transporting cystine out of the cell lysosome. A defect in cystinosin function is followed by cystine accumulation throughout the body, especially the eyes and kidneys.[A218721] Several preparations of cysteamine exist for the treatment of cystinosis manifestations, some in capsule form, and others in ophthalmic solution form.[L15606,L15616] In particular, cystine deposits on the eye can cause significant discomfort throughout the day and require frequent treatment with eye drops, typically every waking hour.[L15611] On August 25th 2020, the first ophthalmic solution for cystinosis requiring only 4 daily treatments was granted FDA approval.[L15606] Cysteamine eye drops are a practical and effective option for those affected by ocular cystinosis. Marketed by Recordati Rare Diseases Inc., CYSTADROPS® reduce the burden of multiple frequent medications normally administered to those with cystinosis.[L15601]
Synonyms
  • MEA
  • Thioethanolamine
  • Mercaptaminum
  • 2-amino-ethanethiol
  • Mercaptamina
Brand Names
  • PROCYSBI Delayed-release
  • Cystadrops
  • Cystaran
  • Cystagon
  • Procysbi
IndicationThe bitartrate salt of cysteamine is used for the oral treatment of nephropathic cystinosis and cystinuria in adults and children ≥6 years old.[L15616] The hydrochloride salt, used in eye drop preparations, is indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.[L15601,L15606]
Categories
  • Alimentary Tract and Metabolism
  • Amines
  • Amino Acids and Derivatives
  • Cystine Depleting Agents
  • Cystine Disulfide Reduction
ATC-Code
  • A16AA04
  • S01XA21
CAS number60-23-1

Drug Targets

NameTarget SequencePharmacological ActionActions
SomatostatinMLSCRLQCALAALSIVLALGCVTGAPSDPRLRQFLQKSLAAAAGKQELAK...unknownbinder
Cystine-unknowncleavage
Neuropeptide Y receptor type 2MGPIGAEADENQTVEEMKVEQYGPQTTPRGELVPDPEPELIDSTKLIEVQ...unknownother/unknown
MyeloperoxidaseMGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAA...unknownsubstrate
AlbuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknownbinder
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 6058, 118985556
ChEMBL CHEMBL602
ChEBI CHEBI:17141
CCDC/CSD XIJKIK01, BILKIS, XIJKIK02, IVAXOV01, IVAXOV, ULUNIB, TEGMIF